Sun J, Ren L, Canel Rivero G, Xu L, Ladabaum U, C Wu J. Generation of two induced pluripotent stem cell lines from patients with Li-Fraumeni Syndrome carrying TP53 mutation. Stem Cell Res. 2024;81:103527 pubmed publisher

Vacante F, Venkateshappa R, Htet M, Yan C, Wu J. Generation of Marfan syndrome-specific induced pluripotent stem cells harboring FBN1 mutations. Stem Cell Res. 2024;80:103518 pubmed publisher

Dai Y, Zhu W, Flores Banuelos A, Li J, Mukherjee S, Algaze C, et al. Generation of two induced pluripotent stem cell lines from patients with Williams syndrome. Stem Cell Res. 2024;78:103460 pubmed publisher

Kaur N, Singh J. Generating human AMN and cALD iPSC-derived astrocytes with potential for modeling X-linked adrenoleukodystrophy phenotypes. bioRxiv. 2024;: pubmed publisher

Gao J, Li J, Xu L, Yan C, Knowles J, Wu J. Generation of two familial hypercholesterolemia patient-specific induced pluripotent stem cell lines harboring heterozygous mutations in the LDLR gene. Stem Cell Res. 2024;78:103463 pubmed publisher

Wang J, Bering J, Alonzo M, Ye S, Texter K, Garg V, et al. Generation of iPSC line NCHi015-A from a patient with truncus arteriosus carrying heterozygous variants in KMT2D and NOTCH1. Stem Cell Res. 2024;78:103457 pubmed publisher

Wang R, Hasegawa M, Suginobe H, Yoshihara C, Ishii Y, Ueyama A, et al. Impaired Relaxation in Induced Pluripotent Stem Cell-Derived Cardiomyocytes with Pathogenic TNNI3 Mutation of Pediatric Restrictive Cardiomyopathy. J Am Heart Assoc. 2024;13:e032375 pubmed publisher

Mullen M, Kojic A, Alamana C, Canel G, Lai C, Knowles J, et al. Generation of two induced pluripotent stem cell lines from healthy patients of African American ancestry. Stem Cell Res. 2024;76:103322 pubmed publisher

Mendonca D, Cappuccio G, Sheppard J, Delacruz M, Bengtsson J, Carvalho C, et al. Generation of five induced pluripotent stem cell lines from patients with MECP2 Duplication Syndrome. Stem Cell Res. 2024;74:103292 pubmed publisher

Aljuhani M, Choudhury T, Yu Y, Ye S, Zhao M, Garg V. Generation and characterization of a human induced pluripotent stem cell line heterozygous for a NOTCH1 mutation (NCHi014-A). Stem Cell Res. 2024;74:103281 pubmed publisher

Melesio J, Bonilauri B, Li A, Pang P, Liao R, Witteles R, et al. Generation of two induced pluripotent stem cell lines from hereditary amyloidosis patients with polyneuropathy carrying heterozygous transthyretin (TTR) mutation. Stem Cell Res. 2024;74:103265 pubmed publisher

Oleksy C, Massart F, Goldwurm S, Arado A, Arena G, Boussaad I, et al. Generation and characterization of induced pluripotent stem cells from a Parkinson's disease patient carrying the digenic LRRK2 p.G2019S and GBA1 p.N409S mutations. Stem Cell Res. 2023;72:103212 pubmed publisher

Chen G, Orozco L, Parmisano S, Jahng J, Vera C, Zhuge Y, et al. Generation of two induced pluripotent stem cell lines from patients suffering from pulmonary hypertension. Stem Cell Res. 2023;72:103218 pubmed publisher

Bonilauri B, Shin H, Htet M, Yan C, Witteles R, Sallam K, et al. Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation. Stem Cell Res. 2023;72:103215 pubmed publisher

Stanberry I, Cunningham D, Ye S, Alonzo M, Zhao M, Garg V, et al. Characterization of an induced pluripotent stem cell line NCHi011-A from a 23-year-old female with Alagille Syndrome harboring a heterozygous JAG1 pathogenic variant. Stem Cell Res. 2023;72:103213 pubmed publisher

Liu W, Zeng W, Kong X, Htet M, Yu R, Wheeler M, et al. Generation of two induced pluripotent stem cell lines from Duchenne muscular dystrophy patients. Stem Cell Res. 2023;72:103207 pubmed publisher

Kong X, Belbachir N, Zeng W, Yan C, Navada S, PEREZ M, et al. Generation of two induced pluripotent stem cell lines from catecholaminergic polymorphic ventricular tachycardia patients carrying RYR2 mutations. Stem Cell Res. 2023;69:103111 pubmed publisher

Zeng W, Kong X, Alamana C, Liu Y, Guzmán J, Pang P, et al. Generation of two induced pluripotent stem cell lines from spinal muscular atrophy type 1 patients carrying no functional copies of SMN1 gene. Stem Cell Res. 2023;69:103095 pubmed publisher

Chemla A, Arena G, Saraiva C, Berenguer Escuder C, Grossmann D, Gr xfc newald A, et al. Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson's disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p.T610A) in the RHOT1 . Stem Cell Res. 2023;69:103085 pubmed publisher

Almad A, Garcia L, Takanohashi A, Gagne A, Yang W, Ann McGuire J, et al. Generation of three induced Pluripotent Stem Cell lines from individuals with Hypomyelination with Atrophy of Basal Ganglia and Cerebellum caused by a c.745G>A (p.D249N) autosomal dominant mutation in TUBB4A. Stem Cell Res. 2023;69:103083 pubmed publisher

Kim A, Lee H, Kim H, Jung J, Seol H, Choi E, et al. Establishment of TUBB3-mCherry knock-in human pluripotent stem cell line using CRISPR/Cas9 (SNUe003-A-4). Stem Cell Res. 2023;69:103064 pubmed publisher

Siles L, Gaud xf3 P, Pomares E. High-Efficiency CRISPR/Cas9-Mediated Correction of a Homozygous Mutation in Achromatopsia-Patient-Derived iPSCs. Int J Mol Sci. 2023;24: pubmed publisher

Yang H, Lee J, Kim J, You J, Kim J, Lee H, et al. Identification of cell-biologic mechanisms of coronary artery spasm and its ex vivo diagnosis using peripheral blood-derived iPSCs. Biomater Res. 2023;27:16 pubmed publisher

Adhicary S, Ye S, Lin H, Texter K, Garg V, Zhao M. Establishment of NCHi009-A, an iPSC line from a patient with hypoplastic left heart syndrome (HLHS) carrying a heterozygous NOTCH1 mutation. Stem Cell Res. 2023;66:103013 pubmed publisher

Jimenez Tellez N, Vera C, Yıldırım Z, Vicente Guevara J, Zhang T, Wu J. Generation of two iPSC lines from long QT syndrome patients carrying SNTA1 variants. Stem Cell Res. 2023;66:103003 pubmed publisher

Lin H, Ye S, Xu Z, Penaloza J, Aljuhani M, Vetter T, et al. Generation and characterization of a human induced pluripotent stem cell (iPSC) line from a patient with congenital heart disease (CHD). Stem Cell Res. 2022;65:102958 pubmed publisher

Yıldırım Z, Kojic A, Yan C, Wu M, Vagelos R, Wu J. Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients caused by heterozygous mutations in the HCN4 gene. Stem Cell Res. 2022;65:102951 pubmed publisher

Kojic A, Kim H, Guevara J, Ravada S, Sallam K, Wu J. Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying heterozygous FLNC mutations. Stem Cell Res. 2022;64:102928 pubmed publisher

Alonzo M, Contreras J, Ye S, Lin H, Hernandez Rosario L, McBride K, et al. Characterization of an iPSC line NCHi006-A from a patient with hypoplastic left heart syndrome (HLHS). Stem Cell Res. 2022;64:102892 pubmed publisher

Contreras J, Alonzo M, Ye S, Lin H, Hernandez Rosario L, McBride K, et al. Generation of an induced pluripotent stem cell line NCHi003-A from a 11-year-old male with pulmonary atresia with intact ventricular septum (PA-IVS). Stem Cell Res. 2022;64:102893 pubmed publisher

Liu J, Black G, Kimber S, Sergouniotis P. Generation of a human induced pluripotent stem cell line carrying the TYR c.575C>A (p.Ser192Tyr) and c.1205G>A (p.Arg402Gln) variants in homozygous state using CRISPR-Cas9 genome editing. Stem Cell Res. 2022;64:102880 pubmed publisher

Caudal A, Mondejar Parre xf1 o G, Vera C, Williams D, Shenoy S, Liang D, et al. Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients. Stem Cell Res. 2022;63:102855 pubmed publisher

Mencke P, Hanss Z, Jarazo J, Massart F, Rybicki A, Petkovski E, et al. Generation of isogenic control DJ-1-delP GC13 for the genetic Parkinson's disease-patient derived iPSC line DJ-1-delP (LCSBi008-A-1). Stem Cell Res. 2022;62:102815 pubmed publisher

Mencke P, Boussaad I, Onal G, Kievit A, Boon A, Mandemakers W, et al. Generation and characterization of a genetic Parkinson's disease-patient derived iPSC line DJ-1-delP (LCSBi008-A). Stem Cell Res. 2022;62:102792 pubmed publisher

Jeong J, Kim T, Kim M, Jung Y, Kim K, Shim S, et al. Elimination of Reprogramming Transgenes Facilitates the Differentiation of Induced Pluripotent Stem Cells into Hepatocyte-like Cells and Hepatic Organoids. Biology (Basel). 2022;11: pubmed publisher

Lee H, Kim A, Hwang S, Jung J, Seol H, Sung J, et al. Generation of αMHC-EGFP knock-in in human pluripotent stem cell line, SNUe003-A-3 using CRISPR/Cas9-based gene targeting. Stem Cell Res. 2022;61:102779 pubmed publisher

Cho S, Lee C, Lai C, Zhuge Y, Haddad F, Fowler M, et al. Heterozygous LMNA mutation-carrying iPSC lines from three cardiac laminopathy patients. Stem Cell Res. 2022;59:102657 pubmed publisher

Iannello G, Patel A, Sirabella D, Corneo B, Thaker V. Derivation and characterization of the induced pluripotent stem cell line CUIMCi004-A from a patient with a novel frameshift variant in exon 18a of OCRL. Stem Cell Res. 2021;59:102635 pubmed publisher

Lee C, Cho S, Lai C, Shenoy S, Vagelos R, Wu J. Generation of three iPSC lines from dilated cardiomyopathy patients carrying a pathogenic LMNA variant. Stem Cell Res. 2021;59:102638 pubmed publisher

Belbachir N, Lai C, Rhee J, Zhuge Y, PEREZ M, Sallam K, et al. Generation of two induced pluripotent stem cell lines from Brugada syndrome affected patients carrying SCN5A mutations. Stem Cell Res. 2021;57:102605 pubmed publisher

Machowska M, Bearzi C, Piekarowicz K, x141 aczma x144 ska I, Rzepecki R. Generation of one control and four iPSCs clones from patients with Emery-Dreifuss muscular dystrophy type 1. Stem Cell Res. 2021;55:102487 pubmed publisher

Zhang H, Jahng J, Liu Y, Chase A, PEREZ M, Wu J. Generation of three induced pluripotent stem cell lines (SCVIi014-A, SCVIi015-A, and SCVIi016-A) from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene. Stem Cell Res. 2021;55:102492 pubmed publisher

Cao X, Jahng J, Lee C, Zha Y, Wheeler M, Sallam K, et al. Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYH7 mutations. Stem Cell Res. 2021;55:102455 pubmed publisher

Iannello G, Patel A, Sirabella D, Corneo B, Thaker V. Generation of the iPSC line CUIMCi003-A derived from a patient with severe early onset obesity. Stem Cell Res. 2021;54:102432 pubmed publisher

Figiel Dabrowska A, Radoszkiewicz K, Rybkowska P, Krzesniak N, Sulejczak D, Sarnowska A. Neurogenic and Neuroprotective Potential of Stem/Stromal Cells Derived from Adipose Tissue. Cells. 2021;10: pubmed publisher

Jahng J, Black K, Liu L, Bae H, Perez M, Ashley E, et al. Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene. Stem Cell Res. 2021;53:102284 pubmed publisher

Boussaad I, Cruciani G, Bolognin S, Antony P, Dording C, Kwon Y, et al. Integrated, automated maintenance, expansion and differentiation of 2D and 3D patient-derived cellular models for high throughput drug screening. Sci Rep. 2021;11:1439 pubmed publisher

Sarvestani S, SIGNS S, Hu B, Yeu Y, Feng H, Ni Y, et al. Induced organoids derived from patients with ulcerative colitis recapitulate colitic reactivity. Nat Commun. 2021;12:262 pubmed publisher

Pagliari S, Vinarsky V, Martino F, Perestrelo A, Oliver De La Cruz J, Caluori G, et al. YAP-TEAD1 control of cytoskeleton dynamics and intracellular tension guides human pluripotent stem cell mesoderm specification. Cell Death Differ. 2021;28:1193-1207 pubmed publisher

Zhang Y, Li Y, Hu Q, Xi Y, Xing Z, Zhang Z, et al. The lncRNA H19 alleviates muscular dystrophy by stabilizing dystrophin. Nat Cell Biol. 2020;22:1332-1345 pubmed publisher

Barbuti P, Antony P, Santos B, Massart F, Cruciani G, Dording C, et al. Using High-Content Screening to Generate Single-Cell Gene-Corrected Patient-Derived iPS Clones Reveals Excess Alpha-Synuclein with Familial Parkinson's Disease Point Mutation A30P. Cells. 2020;9: pubmed publisher

Barbuti P, Santos B, Dording C, Cruciani G, Massart F, Hummel A, et al. Generation of two iPS cell lines (HIHDNDi001-A and HIHDNDi001-B) from a Parkinson's disease patient carrying the heterozygous p.A30P mutation in SNCA. Stem Cell Res. 2020;48:101951 pubmed publisher

Duarte A, Ribeiro D, Santos R, Moreira L, Braganca J, Amaral O. Induced pluripotent stem cell line (INSAi002-A) from a Fabry Disease patient hemizygote for the rare p.W287X mutation. Stem Cell Res. 2020;45:101794 pubmed publisher

Larsen S, Hanss Z, Cruciani G, Massart F, Barbuti P, Mellick G, et al. Induced pluripotent stem cell line (LCSBi001-A) derived from a patient with Parkinson's disease carrying the p.D620N mutation in VPS35. Stem Cell Res. 2020;45:101776 pubmed publisher

Lu C, Sanjana N. Generation of a knock-in MAP2-tdTomato reporter human embryonic stem cell line with inducible expression of NEUROG2/1 (NYGCe001-A). Stem Cell Res. 2019;41:101643 pubmed publisher

Duarte A, Ribeiro D, Santos R, Moreira L, Braganca J, Amaral O. Induced pluripotent stem cell line (INSAi001-A) from a Gaucher disease type 3 patient compound heterozygote for mutations in the GBA1 gene. Stem Cell Res. 2019;41:101595 pubmed publisher

Kanton S, Boyle M, He Z, Santel M, Weigert A, Sanchís Calleja F, et al. Organoid single-cell genomic atlas uncovers human-specific features of brain development. Nature. 2019;574:418-422 pubmed publisher

Park S, Yoo J, Lee D, Jang J, Cho M, Kim D, et al. Establishment of PITX3-mCherry knock-in reporter human embryonic stem cell line (WAe009-A-23). Stem Cell Res. 2019;39:101499 pubmed publisher

Maguire J, Gagne A, Gonzalez Alegre P, Davidson B, Shakkottai V, Gadue P, et al. Generation of Spinocerebellar Ataxia Type 2 induced pluripotent stem cell lines, CHOPi002-A and CHOPi003-A, from patients with abnormal CAG repeats in the coding region of the ATXN2 gene. Stem Cell Res. 2019;34:101361 pubmed publisher

Gagne A, Maguire J, Gandre Babbe S, Chou S, Tasian S, Loh M, et al. Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL. Stem Cell Res. 2018;31:157-160 pubmed publisher

Nakashima Y, Miyagi Shiohira C, Noguchi H, Omasa T. Atorvastatin Inhibits the HIF1α-PPAR Axis, Which Is Essential for Maintaining the Function of Human Induced Pluripotent Stem Cells. Mol Ther. 2018;26:1715-1734 pubmed publisher

Chen B, Teng J, Liu H, Pan X, Zhou Y, Huang S, et al. Inducible overexpression of RUNX1b/c in human embryonic stem cells blocks early hematopoiesis from mesoderm. J Mol Cell Biol. 2017;9:262-273 pubmed publisher

Nam Y, Rim Y, Jung S, Ju J. Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration. Stem Cell Res Ther. 2017;8:16 pubmed publisher

Shinozawa T, Nakamura K, Shoji M, Morita M, Kimura M, Furukawa H, et al. Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes. Stem Cell Reports. 2017;8:226-234 pubmed publisher

Altomare C, Pianezzi E, Cervio E, Bolis S, Biemmi V, Benzoni P, et al. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade. Europace. 2016;18:iv67-iv76 pubmed publisher

Dzamko N, Gysbers A, Perera G, Bahar A, Shankar A, Gao J, et al. Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology. Acta Neuropathol. 2017;133:303-319 pubmed publisher

Kim Y, Rim Y, Yi H, Park N, Park S, Ju J. The Generation of Human Induced Pluripotent Stem Cells from Blood Cells: An Efficient Protocol Using Serial Plating of Reprogrammed Cells by Centrifugation. Stem Cells Int. 2016;2016:1329459 pubmed publisher

Krueger W, Tanasijevic B, Barber V, Flamier A, Gu X, MANAUTOU J, et al. Cholesterol-secreting and statin-responsive hepatocytes from human ES and iPS cells to model hepatic involvement in cardiovascular health. PLoS ONE. 2013;8:e67296 pubmed publisher

Furusawa T, Ohkoshi K, Kimura K, Matsuyama S, Akagi S, Kaneda M, et al. Characteristics of bovine inner cell mass-derived cell lines and their fate in chimeric conceptuses. Biol Reprod. 2013;89:28 pubmed publisher

Szablowska Gadomska I, Sypecka J, Zayat V, Podobinska M, Pastwińska A, Pienkowska Grela B, et al. Treatment with small molecules is an important milestone towards the induction of pluripotency in neural stem cells derived from human cord blood. Acta Neurobiol Exp (Wars). 2012;72:337-50 pubmed